BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.51) per share. This is a 1.92 percent increase over losses of $(0.52) per share from the same period last year.
BridgeBio Pharma Q3 EPS $(0.51) Up From $(0.52) YoY
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.51) per share. This is a 1.92 percent increase over losses of $(0.52) per share from the same period last year.
Benzinga · 11/07/2019 21:50